Epidemiology of diabetes mellitus in Bulgaria

Koeva, L.; Koev, D

doi:10.14748/bmr.v5.183

Cited by 3 publications

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of diagnosed diabetes among Bulgarians of all ages increased from 0.19% [5] to 9.55% in 2012 [6,7]. About a quarter of person with diabetes are unaware that they have the disease.…”

Section: Introductionmentioning

confidence: 99%

Quality of Life in Patients with Type 2 Diabetes Mellitus in Bulgaria: A Cross - Sectional Study

Levterova¹

2016

EJPM

View full text Add to dashboard Cite

Diabetes Mellitus is a disease that affects almost every aspect of patients' life. Socio-medical importance and continuously increasing financial costs of diabetes require a thorough research on the quality of life in these patients to optimize clinical management and increase the effectiveness of health interventions. The aim of the study is to assess the quality of life in patients with type 2 diabetes mellitus. Materials and A cross-sectional study was conducted in 90 patients with type 2 diabetes mellitus (T2DM) in Bulgaria. Health-related quality of life was measured using the 36-item Short-Form Health Survey (SF-36). The study result showed that the participants' age ranged from 32 to 88 years old, with mean of 63.0 years (standard deviation (SD) 0.96). Less than half were females (52.9%), married (74.3%) and living in urban areas (61.4%). Diabetes negative impact is observed on all life aspects. The duration of disease (diabetes duration) and diabetes complication seem to be the most influential factors which negatively and statistically significant affect all the SF-36 subscales. It concluded that better quality of life of patients with diabetes mellitus type 2 is achieved by preventing complications and effective management of chronic underlying diseases.

show abstract

Section: Introductionmentioning

confidence: 99%

Quality of Life in Patients with Type 2 Diabetes Mellitus in Bulgaria: A Cross - Sectional Study

Levterova¹

2016

EJPM

View full text Add to dashboard Cite

show abstract

“…6 A considerable rise in the prevalence of T2DM has also been observed -from some 0.2% in the 1940s it reached almost 2% in the 1990s and is currently estimated to exceed 8.5%. 7,8 For the same period CVD mortality rates have also gradually increased and Bulgaria is nowadays among the countries with the highest CVD mortality in Europe. 9 These extremely high rates could be accounted for by different factors such as smoking, diet, and consequences of poverty.…”

Section: Introductionmentioning

confidence: 99%

The metabolic syndrome in Bulgaria

Stefanov

Temelkova‐Kurktschiev²

2011

Folia Medica

View full text Add to dashboard Cite

The prevalence of the metabolic syndrome (MetS), a cluster of central obesity, hyper/dyslipiemia, hyperglycemia, and hypertension is constantly increasing worldwide. Although, the exact mechanisms underlying the development of the MetS are not completely understood, modern lifestyle of physical inactivity and unhealthy nutrition, obesity, and their interaction with genetic factors are considered largely responsible. It has been convincingly demonstrated that the metabolic syndrome is associated with substantially increased risk for the development of type 2 diabetes mellitus, as well as, with increased cardiovascular disease (CVD) morbidity and mortality. The prevalence of obesity and type 2 diabetes in Bulgaria has dramatically increased in the last decades. For the same period CVD mortality in the country have also gradually increased and Bulgaria is nowadays among the countries with the highest macrovascular disease death rates in Europe. A number of epidemiological studies have demonstrated that the prevalence of the MetS and of its individual components has also increased during the last decades and is nowadays relatively high among the general population in Bulgarian and extremely high among high-risk individuals. Surprisingly, the prevalence of the MetS is also high among the low risk population in the country and most of its components that are independent predictors of CVD mortality are largely undiagnosed. Furthermore, the presence of the MetS is associated with history of myocardial infarction in the country. Although objective data is somewhat scarce, several studies have reported association of the low physical activity level and the unhealthy nutritional habits with the prevalence of cardiometabolic diseases among the Bulgarian population. Taking into account these observations it may be suggested that indeed the high metabolic syndrome prevalence that results as a consequence of unhealthy lifestyle is responsible for the extremely high CVD mortality rates in Bulgaria. Therefore, largescale screening programmes should be undertaken within this population in combination with health prevention strategies promoting regular physical activity and improvement of nutritional habits.

show abstract